AIMS/HYPOTHESIS: GFR is commonly estimated using the four-variable Modification of Diet in Renal Disease (MDRD) formula and this forms the basis for classification of chronic kidney disease (CKD). We investigated the effect of obesity on the estimation of glomerular filtration rate in type 2 diabetic participants with CKD. METHODS: We enrolled 111 patients with type 2 diabetes mellitus in different stages of CKD. GFR was measured using (51)Cr-labelled EDTA plasma clearance and was estimated using the four-variable MDRD formula. RESULTS: The bias between estimated and measured GFR was -22.4 (-33.8 to -11.0) p < 0.001 in the obese group compared with -6.04 (-17.6 to -5.5) p = 0.299 in the non-obese group. When GFR was indexed to body surface area of 1.73 m(2), the bias remained significant at -9.4 (-13.4 to -5.4) p < 0.001 in the obese participants. CONCLUSIONS/ INTERPRETATION: This study suggests that the four-variable MDRD formula significantly underestimates GFR in obese type 2 diabetic participants with CKD.
AIMS/HYPOTHESIS: GFR is commonly estimated using the four-variable Modification of Diet in Renal Disease (MDRD) formula and this forms the basis for classification of chronic kidney disease (CKD). We investigated the effect of obesity on the estimation of glomerular filtration rate in type 2 diabeticparticipants with CKD. METHODS: We enrolled 111 patients with type 2 diabetes mellitus in different stages of CKD. GFR was measured using (51)Cr-labelled EDTA plasma clearance and was estimated using the four-variable MDRD formula. RESULTS: The bias between estimated and measured GFR was -22.4 (-33.8 to -11.0) p < 0.001 in the obese group compared with -6.04 (-17.6 to -5.5) p = 0.299 in the non-obese group. When GFR was indexed to body surface area of 1.73 m(2), the bias remained significant at -9.4 (-13.4 to -5.4) p < 0.001 in the obeseparticipants. CONCLUSIONS/ INTERPRETATION: This study suggests that the four-variable MDRD formula significantly underestimates GFR in obese type 2 diabeticparticipants with CKD.
Authors: Mark E Molitch; Ralph A DeFronzo; Marion J Franz; William F Keane; Carl Erik Mogensen; Hans-Henrik Parving; Michael W Steffes Journal: Diabetes Care Date: 2004-01 Impact factor: 19.112
Authors: John S Fleming; Maureen A Zivanovic; Glen M Blake; Maria Burniston; Philip S Cosgriff Journal: Nucl Med Commun Date: 2004-08 Impact factor: 1.690
Authors: Richard A Chudleigh; Gareth Dunseath; Rajesh Peter; John N Harvey; Richard L Ollerton; Steve Luzio; David R Owens Journal: Diabetes Care Date: 2007-10-12 Impact factor: 19.112
Authors: F Iliadis; T Didangelos; A Ntemka; A Makedou; E Moralidis; A Gotzamani-Psarakou; T Kouloukourgiotou; D Grekas Journal: Diabetologia Date: 2011-09-23 Impact factor: 10.122
Authors: M C Thomas; J L Moran; V Harjutsalo; L Thorn; J Wadén; M Saraheimo; N Tolonen; J Leiviskä; A Jula; C Forsblom; P H Groop Journal: Diabetologia Date: 2012-02-10 Impact factor: 10.122
Authors: Michael Resl; Greisa Vila; Roland Kraxner; Richard Pacher; Anton Luger; Martin Hülsmann; Stephanie Neuhold; Helmut Brath; Rudolf Prager; Martin Clodi Journal: Wien Klin Wochenschr Date: 2013-09-06 Impact factor: 1.704